Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Total Immunoglobulin E (IgE)

K-Number: K220178 · 2022-03-23

Decision Date2022-03-23
Product CodeDGC
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

Total Immunoglobulin E (IgE) is a medical device manufactured by Beckman Coulter, Inc.. It received FDA 510(k) clearance on 2022-03-23 under approval number K220178. The device is classified under product code DGC. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Total Immunoglobulin E (IgE)?

Total Immunoglobulin E (IgE) is a medical device that received FDA 510(k) clearance on 2022-03-23. It is manufactured by Beckman Coulter, Inc.. The 510(k) number is K220178.

When was Total Immunoglobulin E (IgE) approved by the FDA?

Total Immunoglobulin E (IgE) received FDA 510(k) clearance on 2022-03-23, under approval number K220178.

What company makes Total Immunoglobulin E (IgE)?

Total Immunoglobulin E (IgE) is manufactured by Beckman Coulter, Inc..

What is the FDA product code for Total Immunoglobulin E (IgE)?

The FDA product code for Total Immunoglobulin E (IgE) is DGC.

Other Devices by Beckman Coulter, Inc.

View all 77 devices →

Related Devices (Code: DGC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.